AI Month roundup: From ethical algorithms to robots that learn Amy Gutmann Hall will open in 2024 and will be the home of the new B.S.E. in Artificial Intelligence for faculty and students. nocred AI Month roundup: From ethical algorithms to robots that learn During the month of April, Penn’s School of Engineering and Applied Science showcased a series of news items exploring the evolving world of artificial intelligence.
Adding (or subtracting) a spouse or partner? Changes can be made during Penn’s Open Enrollment nocred Adding (or subtracting) a spouse or partner? Changes can be made during Penn’s Open Enrollment This year’s Open Enrollment period for reviewing and updating benefits is April 29 through May 10, with several new options offered for families and individuals.
Nurses across the U.S. cite employer failures as their top reason for leaving Image: Adobe stock Nurses across the U.S. cite employer failures as their top reason for leaving A new Penn Nursing study highlights the fact that health care employers could retain more nurses through solutions that enhance nurses’ work-life balance.
Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy.
A hopeful time for Cryptosporidium research A lot of research progress has been over the past decade on Cryptosporidium, a single-celled parasite that is one of the leading causes of deadly diarrheal disease, and Penn Vet professors brought together researchers and clinicians from around the world for a conference. (Image: Muthgapatti Kandasamy and Boris Striepen) A hopeful time for Cryptosporidium research Boris Striepen of Penn Vet organized the First Biennial Cryptosporidium Meeting, bringing together researchers and clinicians from around the world to discuss the problems and progress around the parasite and the diarrheal disease it causes.
Soft support can make unexpectedly stable glass Image: iStock / Gloria Sonda Soft support can make unexpectedly stable glass A team of researchers from Penn and the Brookhaven National Laboratory find a new way to manufacture stable glass.
Reading James Baldwin for a 21st century world Nuri Yi, a Lotus member and second-year grad student in the Department of Biology in the School of Arts & Sciences, leads a discussion of Baldwin’s work at Kelly Writers House.nocred Reading James Baldwin for a 21st century world To commemorate Baldwin’s approaching centennial, the Lotus Collective is hosting weekly readings and discussions of his work at Kelly Writers House.
Structural elements of archaea Archaea, a unique domain of life, were discovered in the 1970s in extreme environments such as hot springs and salty lakes, with notable early studies conducted in locations like Yellowstone National Park in the United States. Initially considered unusual bacteria, their distinct genetics and biochemistry led to their recognition as a separate domain, emphasizing microbial diversity and evolutionary complexity. (Image: iStock / rmbarricarte) Structural elements of archaea Researchers shed light on archea, a single cell microorganism, to discover how proteins determine what shape a cell will take and how that form may function.
When do stereotypes undermine indirect reciprocity? iStock / bakhtiar_zein When do stereotypes undermine indirect reciprocity? Researchers from Penn and Princeton develop a model to evaluate how reputation and indirect reciprocity affects cooperative behaviors.
‘Switchable’ bispecific antibodies pave way for safer cancer treatment Bispecific T cell engagers are emerging as a powerful class of immunotherapy to treat cancer but are sometimes hindered by unwanted outcomes, such as on-target, off-tumor toxicity; cytokine release syndrome; and neurotoxicity. Now, researchers Penn researchers have developed a novel “switchable” bispecific T cell engager that mitigates these negative effects by co-opting a drug already approved by the FDA. (Image: iStock / CIPhotos) ‘Switchable’ bispecific antibodies pave way for safer cancer treatment Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy.